الوقائع الإخبارية
الوقائع الإخبارية
Ready to play
Ready to play
The Public Authority for Food and Drug Administration announced the registration of the first locally produced vaccine against pneumococcal bacteria in Jordan. It is known as TQ-PCV VAX 13-valent Pneumococcal Polysaccharide Conjugate Vaccine, manufactured through a contract with the Chinese company Walvax for Taqaddum for Pharmaceuticals. This vaccine helps protect children aged three months to five years from infectious diseases caused by 13 types of pneumococcal bacteria by strengthening their immune system. This achievement comes after the completion of all technical and scientific evaluation requirements and represents an important step in strengthening the local pharmaceutical industry and drug security in Jordan. It also elevates the kingdom’s status as a regional hub for pharmaceutical industries and innovation.
Notice: This Is an AI-Generated Summary
Comments (0)